Fischer to show digital mammography work
Like competitors Bennett X-Ray and Lorad, Fischer of Denver isdeveloping a full-view digital mammography system. In its RSNAbooth, the company for the first time will display a working prototypeof its full-view digital system and will show patient images
Like competitors Bennett X-Ray and Lorad, Fischer of Denver isdeveloping a full-view digital mammography system. In its RSNAbooth, the company for the first time will display a working prototypeof its full-view digital system and will show patient images acquiredwith a prototype installed at Thomas Jefferson University Hospitalin Philadelphia.
Fischer's prototype has a design similar to a standard mammographyunit, but it features a detector array more closely resemblingthat used on CT scanners, according to Anthony DeCarolis, vicepresident of sales and marketing. The array enables cliniciansto perform 3-D imaging of the breast. The array has a matrix of1024 x 1024, which results in a high-resolution image that canimprove visualization of minute calcifications, DeCarolis said.
Fischer will also display an improved Mammotest prone stereotacticbiopsy table, as well as enhancements in its MammoVision CCD cameratechnology used with its digital spot-film device. Fischer isworking on a CCD camera design that can be moved from the Mammotesttable to an upright mammography system to make digitally guidedstereotactic exams more convenient and affordable.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
